>These domestic rescheduling may have an affect on legal charges or banking, but cannot address the overarching classifier of Schedule 1 drugs which is the UN based on the 1st link.
So, you're acknowledging that changes to legal charges, banking capabilities and so forth are benefits that come from this reclassification, but you're also calling this change "utter bullshit" and a "red herring"?